A NEW CLASS OF MEDICINES

Meet the Dreamers

The Dreamers are the ones who realized that the discovery of RNAi had the potential to transform the way we treat disease. They were steadfast in their pursuit, even in the face of potential failure, of the chance to develop new treatments for patients. This was the origin of RNAi therapeutics, a potential new class of medicines.

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site